Advertisement

Clinical and Pharmacologic Characterization and Treatment of Potentially Malignant Arrythmias of Chronic Chagasic Cardiomyopathy

  • P. A. Chiale
  • M. B. Rosenbaum
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 89)

Abstract

Chagas’ disease is a widespread parasitosis affecting most Latin American countries (Carcavallo 1975; Coura 1966; Marinkelle 1975; Osimani 1972; Ponce and Zeledon 1973). The etiologic agent is a protozoan, Trypanosoma cruzi 1. This parasite is commonly transmitted to humans by hematophagous insects generically known as “triatomes,” although transmission by blood transfusion is not infrequent, and congenital infection can also occur.

Keywords

Ventricular Tachycardia Ventricular Arrhythmia Right Bundle Branch Block Ventricular Premature Beat Ventricular Extrasystole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bigger JT Jr (1983) Definition of benign versus malignant ventricular arrhythmias: targets for treatment. Am J Cardiol 52: 47C–54CPubMedCrossRefGoogle Scholar
  2. Brener Z (1982) Recent developments in the field of Chagas’ disease. Bull WHO 60: 463–473PubMedGoogle Scholar
  3. Carcavallo RV (1975) Aspects of the epidemiology of Chagas’ disease in Venezuela and Argentina. In: Pan American Health Organization (ed) American trypanosomiasis research. Pan American Health Organization, Washington DC, pp 374–383Google Scholar
  4. Chiale PA, Halpern MS, Nau GJ, Przybylski J, Tambussi AM, Lázzari JO, Elizari MV, Rosenbaum MB (1982) Malignant ventricular arrhythmias in chronic chagasic myocarditis. PACE 5: 162–172PubMedGoogle Scholar
  5. Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, Lázzari JO, Elizari MV, Rosenbaum MB (1984) Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. Am Heart H 107: 656–665CrossRefGoogle Scholar
  6. Coura JR (1966) Contribuçao ao estudo da doença de Chagas no estado de Guanabara. Rev Bras Malariol Doen9as Trop 18: 9–15Google Scholar
  7. Duff HJ, Roden D, Primum K, Oates JA, Woosley RL (1983) Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose related side effects by combination with quinidine. Circulation 67: 1124–1128PubMedCrossRefGoogle Scholar
  8. Elizari MV, Levi RJ, Novakoski A, Làzzari JO, Vetulli HM (1980) Cellular effects of antiarrhythmic drugs. Remarks on methodology. VIII European Congress of Cardiology, Paris, p 11Google Scholar
  9. Faria CAF, Veloso C, Carvallo CA (1983) Parassístole ventricular dupla espontánea em paciente portador de cardiopatia chagasica. Relato de um caso. Arq Bras Cardiol 41: 385–388PubMedGoogle Scholar
  10. Haedo AH, Chiale PA, Bandieri JD, Làzzari JO, Elizari MV, Rosenbaum MB (1986) Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetilajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms. J Am Coll Cardiol. 7: 1114–1120PubMedCrossRefGoogle Scholar
  11. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone. Clinical efficacy and electrophysiology during long- term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 305: 539–547PubMedCrossRefGoogle Scholar
  12. Holt DW, Tucker GT, Jackson PR, Storey GCA (1983) Amiodarone pharmacokinetics. Am Heart J 106: 788–797CrossRefGoogle Scholar
  13. Jorge PAR, Nogueira EA, Bittencourt LAK, Fortuna ABP, Terzi RGG, Vieira RW (1978) Arritmia cardiaca a lesao apical na cardiopatia chagasica cronica. Considerares a respeito de un caso. Arq Bras Cardiol 31: 135–137PubMedGoogle Scholar
  14. Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB (1981) Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation 64: 273–279PubMedCrossRefGoogle Scholar
  15. Kirchhoff LV, Neva FA (1985) Chagas’ disease in Latin American immigrants. JAMA 254: 3058–3060PubMedCrossRefGoogle Scholar
  16. Lamourier EN, Herrmann JLV, Martinez Filho EE, Buffolo E, De Andrade JCS, Korkes H, Schubsky V, Ferreira C, Barcellini A, Portugal OP (1975) Aneurismectomia como tratamento de taquiarritmias refratarias en pacientes portadores de aneurisma ventricular de etiologia chagasica. Arq Bras Cardiol 28: 549–555PubMedGoogle Scholar
  17. Leahey EB Jr, Heissenbuttel RH, Giardina EGV, Bigger JT Jr (1980) Combined mexiletine and propranolol treatment of refractory ventricular tachycardia. Br Med J [Clin Res] 281: 357–358CrossRefGoogle Scholar
  18. Marinkelle CJ (1975) Epidemiology of Chagas’ disease in Colombia. In: Pan American Health Organization (ed) American trypanosomiasis research. Pan American Health Organization, Washington DC, pp 340–345Google Scholar
  19. Nademanee K, Hendrickson BS, Cannon DS, Goldreyer BN, Singh BN (1981) Control of refractory life-threatening ventricular arrhythmias by amiodarone. Am Heart J 101: 759–768PubMedCrossRefGoogle Scholar
  20. Nademanee K, Singh BN, Cannon DS, Weiss S, Feld G, Stevenson WG (1983) Control of sudden recurrent arrhythmic deaths: role of amiodarone. Am Heart J 106: 895–901PubMedCrossRefGoogle Scholar
  21. Nau GJ, Acunzo RS, Sáleme JP, Aldariz A, Elizari MV, Rosenbaum MB (1985) Características clínicas, evaluación y pronóstico de las parasistolias ventriculares. Rev Arg Cardiol 53: 553 (Abstract)Google Scholar
  22. Osmani JJ (1972) Epidemiología de la enfermedad de Chagas en Uruguay. In: Secretaría de Salud Pública de la República Argentina (ed) Simposio Internacional sobre Enfermedad de Chagas. Buenos Aires, pp 209–214Google Scholar
  23. Pearlman JD (1983) Chagas’ disease in Northern California. No longer an endemic diagnosis. Am J Cardiol 75: 1057–1060Google Scholar
  24. Peralta JM (1981) Auto-antibodies and chronic Chagas’ heart disease. Trans R Soc Trop Med Hyg 75: 568–569PubMedCrossRefGoogle Scholar
  25. Ponce C, Zeledon R (1973) La enfermedad de Chagas en Honduras. Bol Of Sanit Panam 75: 239–247Google Scholar
  26. Prata A (1975) Natural history of chagasic cardiomyopathy. In: Pan American Health Organization (ed) American trypanosomiasis research. Washington DC, p 191Google Scholar
  27. Reis Lopes E, Chapadeiro E, Almeida HC, Rocha A, Prata A (1974) Doença de Chagas e morte subita. X Congreso Brasileiro de patología e i encontro Luso-Brasileiro de anatomía patológica. Curitiba, Paraná, Brazil (Abstract)Google Scholar
  28. Reis Lopes E, Chapadeiro E, Almeida HC, Rocha A (1976) Contribusao ao estudo de anatomía patológica dos cora5oes de chagasicos falecidos súbitamente. Rev Soc Bras Med Trop 9: 269–279Google Scholar
  29. Ribeiro dos Santos R, Hudson L (1980) Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clin Exp Immunol 40: 36–41PubMedGoogle Scholar
  30. Rosenbaum MB (1964) Chagasic myocardiopathy. Prog Cardiovasc Dis 7: 199–225PubMedCrossRefGoogle Scholar
  31. Rosenbaum MB, Chiale PA, Haedo AH, Elizari MV (1983) Ten years of experience with amiodarone. Am Heart J 101: 957–964CrossRefGoogle Scholar
  32. Sachs RN, Lanfranchi J (1978) Cardiomyopathies primitives et anomalies immunitaires. Coeur Med Int 17: 193–198Google Scholar
  33. Schmidberg JM, Acunzo RS, Nau GJ, Elizari MV, Rosenbaum MB (1985) Eficacia del nadolol en el tratamiento de las arritmias ventriculares inducidas o agravadas por la ergometría. Rev Arg Cardiol 53: S130 (Abstract)Google Scholar
  34. Sobol SM, Rakita L (1982) Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. Circulation 65: 819–822PubMedCrossRefGoogle Scholar
  35. Waleffe A, Mary-Rabine L, Legrand V, Demoulin JCL, Kulbertus HE (1980) Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. Am Heart J 100: 788–793PubMedCrossRefGoogle Scholar
  36. Winkle RA (1978) Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy. Circulation 57: 1116–1120PubMedGoogle Scholar
  37. Winkle RA, Meffin PJ, Harrison DC (1978 a) Long-term tocainide therapy for ventricular arrhythmias. Circulation 57: 1008–1011PubMedGoogle Scholar
  38. Winkle RA, Gradman AH, Fitzgerald JW (1978 b) Antiarrhythmic drug effect assessed from ventricular arrhythmias reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide, and quinidine. Am J Cardiol 42: 473–484PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • P. A. Chiale
  • M. B. Rosenbaum

There are no affiliations available

Personalised recommendations